サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1499422

腸疾患検査の世界市場：製品、疾患タイプ、診断技術、検査場所別 - 予測（2024年～2030年）

Enteric Disease Testing Market by Product (Consumables, Kits, Reagents), Disease Type (Bacterial, Parasitic, Viral), Diagnostic Techniques, Testing Site - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
腸疾患検査の世界市場：製品、疾患タイプ、診断技術、検査場所別 - 予測（2024年～2030年）
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腸疾患検査の市場規模は、2023年に43億1,000万米ドルとなり、2024年には45億4,000万米ドルに達し、CAGR5.47％で2030年には62億6,000万米ドルに達すると予測されています。

腸疾患検査には、消化管に影響を及ぼす感染症の原因となる病原体の特定を目的としたさまざまな診断手順が含まれます。このような疾患の管理および蔓延防止には、早期かつ正確な診断が重要な役割を果たすことから、腸疾患検査のニーズは、世界の腸疾患の蔓延、診断技術の進歩、意識およびヘルスケア支出の増加などの要因によって高まっています。しかし、先進的な検査技術に伴う高額な費用、低資源環境でのアクセス制限、検査の実施と解釈に熟練した人材の必要性などの課題に直面しています。このような問題に対処するため、資源に制約のある環境も含めて広く展開できる、費用対効果が高く使いやすい診断ソリューションの開発に、現在も焦点が当てられています。分子診断学、ポイントオブケア検査、検査の精度とスピードを向上させる人工知能と機械学習の応用の統合により、検査手順が多様化することが期待されます。

主な市場の統計
基準年 [2023] 43億1,000万米ドル
推定年 [2024] 45億4,000万米ドル
予測年 [2030] 62億6,000万米ドル
CAGR（%） 5.47%

地域別洞察

南北アメリカ、特に米国とカナダでは、強固なヘルスケアシステムと高額な医療費に牽引され、分子診断薬やポイントオブケア検査を含む高度診断ソリューションの採用率が高くなっています。この地域の企業は、規制環境が整備され、研究開発に多額の投資が行われているため、迅速な技術革新と腸疾患検査ソリューションの生産が可能となっています。アジア太平洋では、コレラや腸チフスなどの疾患に対する意識の高まりと医療費の増加に伴い、腸疾患診断薬の需要が拡大しています。しかし、同市場は先進的な診断法と伝統的な診断法が混在しているのが特徴で、国によってヘルスケアインフラに大きな差があります。アジア太平洋の生産は拡大しており、既存のグローバル企業とともに現地企業が台頭しています。欧州・中東・アフリカは多様な様相を呈しており、西欧の高度に発展した市場では最先端の診断技術が採用されている一方、アフリカや中東の一部の国々では、腸疾患検査へのアクセスや購入のしやすさに関する課題に取り組んでいます。欧州・中東・アフリカ各国の規制環境は大きく異なり、新技術の採用ペースに影響を与えています。欧州・中東・アフリカで事業を展開する企業は、多様な患者集団のニーズを満たすため、技術革新とコスト効率の高い生産のバランスをとっています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは、腸疾患検査市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、腸疾患検査市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査対象基準年に観察された蓄積、断片化の優位性、合併特性などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界市場で確固たる足場を築こうとする組織にとって不可欠です。企業は、腸疾患検査市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 衛生状態の悪さと汚染水の供給による腸疾患の蔓延
      • 診断検査における技術革新により、感度、特異性が向上し、結果が早く出るようになったこと
      • 感染症対策に向けた政府および非政府組織の取り組み
    • 抑制要因
      • 新興国における高度な検査の高コストとインフラの不足
    • 機会
      • ヘルスケアインフラへの投資の増加と予防診断への重点
      • 研究開発活動と市場拡大のための戦略的パートナーシップとコラボレーション
    • 課題
      • 製品の承認および商品化に関する規制
  • 市場セグメンテーション分析
    • 疾患タイプ：細菌検査における多重診断法と分子診断法の採用が増加
    • 検査場所：病院での即時の患者ケアには迅速診断が不可欠
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 腸疾患検査市場：製品別

  • 消耗品
  • キット
  • 試薬

第7章 腸疾患検査市場：疾患タイプ別

  • 細菌性
  • 寄生虫
  • ウイルス性

第8章 腸疾患検査市場：診断技術別

  • 免疫学的検査
  • 分子診断
  • 迅速診断

第9章 腸疾患検査市場：検査場所別

  • 病院
  • ポイントオブケア
  • 独立ラボ

第10章 南北アメリカの腸疾患検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋の腸疾患検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの腸疾患検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析（2023年）
  • FPNVポジショニングマトリックス（2023年）
  • 競合シナリオ分析
    • FDAがMeMed BV Directを全血から承認
    • アヴァクタ、欧州の診断検査メーカーを買収
    • メルク、プロメテウス・バイオサイエンスの買収により免疫学パイプラインを強化
  • 戦略分析と提言

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
  • FIGURE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY CHOLERA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY ESCHERICHIA COLI, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY VIRAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY DIPSTICKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY IN-HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY STANDALONE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 182. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 205. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 267. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 268. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 280. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 282. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 294. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 295. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 296. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 303. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 308. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 309. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 310. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TESTING SITE, 2024-2030 (USD MILLION)
  • TABLE 317. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2018-2023 (USD MILLION)
  • TABLE 322. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY BACTERIAL, 2024-2030 (USD MILLION)
  • TABLE 323. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2018-2023 (USD MILLION)
  • TABLE 324. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC TECHNIQUES, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID DIAGNOSTICS, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE
目次
Product Code: MRR-732E7CFCB4A5

[198 Pages Report] The Enteric Disease Testing Market size was estimated at USD 4.31 billion in 2023 and expected to reach USD 4.54 billion in 2024, at a CAGR 5.47% to reach USD 6.26 billion by 2030.

Enteric disease testing encompasses a variety of diagnostic procedures aimed at identifying pathogens that cause infectious diseases affecting the gastrointestinal tract. Given the critical role of early and accurate diagnosis in managing and preventing the spread of these diseases, the need for enteric disease testing is driven by factors such as the growing global prevalence of enteric diseases, advancements in diagnostic technologies, and increased awareness and healthcare spending. However, the practice faces challenges such as the high costs associated with advanced testing technologies, limited accessibility in low-resource settings, and the need for skilled personnel to conduct and interpret tests. To address these issues, there is an ongoing focus on developing cost-effective and user-friendly diagnostic solutions that can be deployed widely, including in resource-constrained environments. The integration of molecular diagnostics, point-of-care testing, and the application of artificial intelligence and machine learning to improve test accuracy and speed is expected to diversify the testing procedures.

KEY MARKET STATISTICS
Base Year [2023] USD 4.31 billion
Estimated Year [2024] USD 4.54 billion
Forecast Year [2030] USD 6.26 billion
CAGR (%) 5.47%

Regional Insights

In the Americas, especially the United States and Canada, there is a high adoption rate of advanced diagnostic solutions, including molecular diagnostics and point-of-care testing, driven by robust healthcare systems and high healthcare expenditure. Companies in this region benefit from a conducive regulatory environment and significant investment in R&D, leading to rapid innovation and production of enteric disease testing solutions. The APAC region has a growing demand for enteric disease diagnostics due to increasing awareness of diseases such as cholera and typhoid coupled with rising healthcare spending. However, the market is characterized by a mix of advanced and traditional diagnostic practices, with significant variations in healthcare infrastructure across countries. Production in APAC is growing, with local companies emerging alongside established global players. EMEA presents a diverse picture, with highly developed markets in Western Europe employing cutting-edge diagnostic technologies while countries in Africa and parts of the Middle East grapple with challenges related to access and affordability of enteric disease testing. Regulatory environments across EMEA vary widely, affecting the pace of adoption of new technologies. Companies operating in EMEA are balancing innovation with cost-effective production to meet the needs of a diverse patient population.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Enteric Disease Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
      • Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
      • Governmental and non-governmental organizations' initiatives to control infectious diseases
    • Market Restraints
      • High cost of advanced tests and the lack of infrastructure in emerging countries
    • Market Opportunities
      • Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
      • Strategic partnerships and collaborations for R&D activities and market expansion
    • Market Challenges
      • Regulations concerning the approval and commercialization of product
  • Market Segmentation Analysis
    • Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
    • Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Enteric Disease Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Enteric Disease Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

FDA Clears MeMed BV Direct from Whole Blood

MeMed announced that its innovative MeMed BV test, designed for rapid differentiation between bacterial and viral infections, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for whole blood samples. This significant milestone allows healthcare professionals to leverage the MeMed Key analyzer, a leading-edge point-of-care device, to diagnose infections accurately in as little as 15 minutes. This breakthrough underscores MeMed's commitment to advancing host response technology and improving patient care by enabling timely and precise treatment decisions. [Published On: 2023-07-19]

Avacta Acquires European Diagnostic Test Maker

Avacta Group, a notable entity in the biotechnology sector, strategically expanded its portfolio by acquiring Coris Bioconcept SRL, a distinguished European producer of rapid diagnostic test kits. Coris Bioconcept specializes in developing, manufacturing, and commercializing lateral flow tests primarily intended for use by healthcare professionals. The company boasts a robust global distribution network, reaching markets across Europe, Asia, South America, Africa, and Oceania, enhancing its presence and operational reach in diagnostic testing. [Published On: 2023-06-01]

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

Merck, internationally known as MSD, announced its strategic move to acquire Prometheus Biosciences, Inc., a company in the biotechnological realm focusing on precision medicine methodologies for immune-mediated diseases. This acquisition set the transaction at an impressive total equity value of around USD 10.8 billion. Prometheus, recognized for its innovative approach to developing therapeutic and companion diagnostic solutions, is currently in the clinical stage. This partnership underscores Merck's commitment to advancing healthcare solutions by integrating cutting-edge technology and scientific research into its comprehensive portfolio. [Published On: 2023-04-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Enteric Disease Testing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Als Limited, Asure Quality, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerica Inc., bioMerieux SA, Bureau Veritas Group, Cepheid Inc., Coris BioConcept SPRL, DiaSorin, Eurofins Scientific SE, Hardy Diagnostics, Intertek Group PLC, Merck & Co., Inc., Merck KGAA, Meridian Bioscience Inc., Merieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Qiagen N.V., Quest Diagnostics, Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and TUV SUD AG.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Kits
    • Reagents
  • Disease Type
    • Bacterial
      • Cholera
      • Escherichia coli
      • Salmonellosis
    • Parasitic
    • Viral
  • Diagnostic Techniques
    • Immunoassays
    • Molecular Diagnostics
      • PCR
      • Real-time PCR
    • Rapid Diagnostics
      • Dipsticks
      • Lateral Flow Assays
  • Testing Site
    • In-Hospital
    • Point-of-Care
    • Standalone Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of enteric diseases due to poor sanitation and contaminated water supplies
      • 5.1.1.2. Technological innovations in diagnostic tests offer greater sensitivity, specificity, and faster results
      • 5.1.1.3. Governmental and non-governmental organizations' initiatives to control infectious diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced tests and the lack of infrastructure in emerging countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in healthcare infrastructure and the focus on preventive diagnostics
      • 5.1.3.2. Strategic partnerships and collaborations for R&D activities and market expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Regulations concerning the approval and commercialization of product
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Type: Increasing preference for multiplex and molecular diagnostic methods for bacterial testing
    • 5.2.2. Testing Site: Need for rapid diagnostics crucial for immediate patient care in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Enteric Disease Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Kits
  • 6.4. Reagents

7. Enteric Disease Testing Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Bacterial
  • 7.3. Parasitic
  • 7.4. Viral

8. Enteric Disease Testing Market, by Diagnostic Techniques

  • 8.1. Introduction
  • 8.2. Immunoassays
  • 8.3. Molecular Diagnostics
  • 8.4. Rapid Diagnostics

9. Enteric Disease Testing Market, by Testing Site

  • 9.1. Introduction
  • 9.2. In-Hospital
  • 9.3. Point-of-Care
  • 9.4. Standalone Laboratories

10. Americas Enteric Disease Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Enteric Disease Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Enteric Disease Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA Clears MeMed BV Direct from Whole Blood
    • 13.3.2. Avacta Acquires European Diagnostic Test Maker
    • 13.3.3. Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio